Skip to main content

People

The strength of I2D3 lies in the people behind it. Our community brings together leading scientists in pharmacokinetics, peptide design, and antibody engineering, alongside collaborators in biotech, data science, and clinical practice. Together, we’re building the expertise and partnerships needed to transform drug development from the inside out.

Leadership


Member Labs


Scientific Advisors

  • Vishva Dixit — Vice President, Physiological Chemistry, Genentech
  • Raymond Evers – Global Lead, Translational DMPK Sciences, Johnson & Johnson
  • John Karanicolas — Head of Computational Drug Discovery, AbbVie
  • Neil McDonnell — CEO, Seal Rock Therapeutics
  • Josh Pearson — Vice President, head of PDMB, Merck Research Labs
  • Brooke Rock — Associate Vice President, Pharmacokinetics and Drug Metabolism, Amgen
  • Peter Senter — Biotech Co-Founder
  • Matt Thomlinson — EVP and Chief Technology Officer, Electronic Arts